Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones

Metabolism: Clinical and Experimental

Volumn 86, Issue , 2018, Pages 49-60

  Murri, Mora ^a,b   Insenser, María ^a   Fernández Durán, Elena ^a   San Millán, José L ^a   Luque Ramírez, Manuel ^a   Escobar Morreale, Héctor F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Androgens; Estrogens; microRNA; Obesity; Polycystic ovary syndrome; Sex

Indexed keywords

MICRORNA; SEX HORMONE; CIRCULATING MICRORNA; TRANSCRIPTOME;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; GENE EXPRESSION; HIRSUTISM; HUMAN; MALE; METABOLIC DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; BLOOD; CASE CONTROL STUDY; COMPLICATION; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; PROCEDURES; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CIRCULATING MICRORNA; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GONADAL STEROID HORMONES; HUMANS; MALE; OBESITY; POLYCYSTIC OVARY SYNDROME; TRANSCRIPTOME; YOUNG ADULT;

EID: 85043379564     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2018.01.011     Document Type: Article

References (31)

1. Sanchon, R., Gambineri, A., Alpanes, M., Martinez-Garcia, M.A., Pasquali, R., Escobar-Morreale, H.F., Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod 27 (2012), 1209–1216.
2. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W., et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91 (2009), 456–488.
3. Escobar-Morreale, H.F., San Millan, J.L., Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 18 (2007), 266–272.
4. Chen, X., Liang, H., Zhang, J., Zen, K., Zhang, C.Y., Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22 (2012), 125–132.
5. Yao, S., MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation. Biol Proced Online, 18, 2016, 8.
6. Creemers, E.E., Tijsen, A.J., Pinto, Y.M., Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res 110 (2012), 483–495.
7. Bertoli, G., Cava, C., Castiglioni, I., MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 5 (2015), 1122–1143.
8. Long, W., Zhao, C., Ji, C., Ding, H., Cui, Y., Guo, X., et al. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers. Cell Physiol Biochem 33 (2014), 1304–1315.
9. Jiang, L., Huang, J., Chen, Y., Yang, Y., Li, R., Li, Y., et al. Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome. Endocrine 53 (2016), 280–290.
10. Ding, C.F., Chen, W.Q., Zhu, Y.T., Bo, Y.L., Hu, H.M., Zheng, R.H., Circulating microRNAs in patients with polycystic ovary syndrome. Hum Fertil (Camb) 18 (2014), 22–29.
11. Zawadzki, J.K., Dunaif, A., Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Dunaif, A., Givens, J.R., Haseltine, F.P., Merriam, G.R., (eds.) Polycystic ovary syndrome, 1992, Blackwell Scientific Publications, Boston, 377–384.
12. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004), 41–47.
13. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W., et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91 (2006), 4237–4245.
14. Escobar-Morreale, H.F., Sanchon, R., San Millan, J.L., A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 93 (2008), 527–533.
15. Matsuda, M., DeFronzo, R.A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999), 1462–1470.
16. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma insulin and glucose concentrations in man. Diabetologia 28 (1985), 412–419.
17. Mazer, N.A., A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids 74 (2009), 512–519.
18. Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29, 2001, e45.
19. Vlachos, I.S., Zagganas, K., Paraskevopoulou, M.D., Georgakilas, G., Karagkouni, D., Vergoulis, T., et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res 43 (2015), W460–W466.
20. Dweep, H., Gretz, N., miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods, 12, 2015, 697.
21. Murri, M., Insenser, M., Fernandez-Duran, E., San-Millan, J.L., Escobar-Morreale, H.F., Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression. J Clin Endocrinol Metab 98 (2013), E1835–44.
22. Templeton, G.F., A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research. Comm Assoc Inform Syst, 28, 2011.
23. Schneider, M.R., Schmidt-Ullrich, R., Paus, R., The hair follicle as a dynamic miniorgan. Curr Biol 19 (2009), R132–42.
24. Goguet-Rubio, P., Klug, R.L., Sharma, D.L., Srikanthan, K., Puri, N., Lakhani, V.H., et al. Existence of a strong correlation of biomarkers and miRNA in females with metabolic syndrome and obesity in a population of West Virginia. Int J Med Sci 14 (2017), 543–553.
25. Karolina, D.S., Tavintharan, S., Armugam, A., Sepramaniam, S., Pek, S.L., Wong, M.T., et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 97 (2012), E2271–6.
26. Deiuliis, J.A., Syed, R., Duggineni, D., Rutsky, J., Rengasamy, P., Zhang, J., et al. Visceral adipose microRNA 223 is upregulated in human and murine obesity and modulates the inflammatory phenotype of macrophages. PLoS One, 11, 2016, e0165962.
27. Chuang, T.Y., Wu, H.L., Chen, C.C., Gamboa, G.M., Layman, L.C., Diamond, M.P., et al. MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue. J Diabetes Res, 2015, 2015, 943659.
28. Escobar-Morreale, H.F., Samino, S., Insenser, M., Vinaixa, M., Luque-Ramirez, M., Lasuncion, M.A., et al. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem 58 (2012), 999–1009.
29. Unni, S.N., Lakshman, L.R., Vaidyanathan, K., Subhakumari, K.N., Menon, N.L., Alterations in the levels of plasma amino acids in polycystic ovary syndrome–a pilot study. Indian J Med Res 142 (2015), 549–554.
30. Chang, A.Y., Lalia, A.Z., Jenkins, G.D., Dutta, T., Carter, R.E., Singh, R.J., et al. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome. Metabolism 71 (2017), 52–63.
31. Xiong, W., Lin, Y., Xu, L., Tamadon, A., Zou, S., Tian, F., et al. Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population. J Ovarian Res, 10, 2017, 10.